AIM
IMPV

Acrospire Investment Management’s Imperva, Inc. IMPV Stock Holding History

Acrospire Investment Management’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-414
Closed -$20K – 1917
2017
Q2 		$20K Sell
414
-300
-42% -$14K 0.02% 1540
2017
Q1 		$29K Buy
+714
New +$29.8K 0.02% 1388

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acrospire Investment Management's IMPV Position: Q3 2017 in Review

Acrospire Investment Management sold out of Imperva, Inc. (IMPV) in Q3 2017, closing a stake of 414 shares — an estimated $20K sold.

Acrospire Investment Management first reported a position in IMPV in Q1 2017 and held it in 2 quarters. The position peaked at $29K in Q1 2017. 171 funds tracked by Wall St. Rank hold IMPV as of Q3 2017.

  • Acrospire Investment Management reported no remaining Imperva, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 414 Imperva, Inc. shares in Q3 2017, an estimated $20K.
  • Acrospire Investment Management first reported a position in Imperva, Inc. in Q1 2017 and held it in 2 quarters.
  • Acrospire Investment Management's Imperva, Inc. position peaked at $29K in Q1 2017.
  • 171 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.